NYSE: PHYTPyrophyte Acquisition Corp Stock
$11.36+0.01 (+0.09%)
Updated Apr 26, 2024
PHYT Price
$11.36
Fair Value Price
N/A
Market Cap
$159.08M
52 Week Low
$10.54
52 Week High
$11.40
P/E
35.5x
P/B
-12.34x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$6.36M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.01
Operating Cash Flow
-$470k
Beta
0
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
PHYT Overview
Pyrophyte Acquisition Corp. is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the energy transition sector. Pyrophyte Acquisition was incorporated in 2021 and is based in Houston, TX.
Zen Score
–
Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PHYT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PHYT was unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PHYT is good value based on its earnings relative to its share price (35.5x), compared to the US market average (41.14x)
P/E vs Market Valuation
PHYT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more PHYT due diligence checks available for Premium users.
Be the first to know about important PHYT news, forecast changes, insider trades & much more!
PHYT News
Valuation
PHYT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
35.5x
Industry
31.79x
Market
41.14x
PHYT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PHYT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
PHYT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-12.34x
Industry
-14.35x
PHYT's financial health
Profit margin
Revenue
$0.0
Net Income
$1.4M
Profit Margin
0%
PHYT's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$97.6M
Liabilities
$13.0M
Debt to equity
-1.01
PHYT's short-term liabilities ($1.26M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PHYT's long-term liabilities ($11.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PHYT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PHYT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$119.1k
Investing
-$320.0k
Financing
$441.0k
PHYT's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
PHYT vs Shell Company Stocks
Pyrophyte Acquisition Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.